Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

This study has been completed.

Study NCT00658528 Information provided by Eisai Inc.

First Received: April 9, 2008 Last Updated: March 10, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2010
Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)

No publications provided by Eisai Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):